DE69918447D1 - Antivirale kombinationen von lamivudin und adefovir - Google Patents

Antivirale kombinationen von lamivudin und adefovir

Info

Publication number
DE69918447D1
DE69918447D1 DE69918447T DE69918447T DE69918447D1 DE 69918447 D1 DE69918447 D1 DE 69918447D1 DE 69918447 T DE69918447 T DE 69918447T DE 69918447 T DE69918447 T DE 69918447T DE 69918447 D1 DE69918447 D1 DE 69918447D1
Authority
DE
Germany
Prior art keywords
lamivudin
adefovir
antiviral combinations
antiviral
combinations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69918447T
Other languages
English (en)
Other versions
DE69918447T2 (de
Inventor
A Brown
D Condreay
Fraser Gray
Marc Rubin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Application granted granted Critical
Publication of DE69918447D1 publication Critical patent/DE69918447D1/de
Publication of DE69918447T2 publication Critical patent/DE69918447T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DE69918447T 1998-09-18 1999-09-17 Antivirale kombinationen von lamivudin und adefovir Expired - Lifetime DE69918447T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9820420.9A GB9820420D0 (en) 1998-09-18 1998-09-18 Antiviral combinations
GB9820420 1998-09-18
PCT/EP1999/006886 WO2000016755A2 (en) 1998-09-18 1999-09-17 Antiviral combinations of lamivudine and adefovir

Publications (2)

Publication Number Publication Date
DE69918447D1 true DE69918447D1 (de) 2004-08-05
DE69918447T2 DE69918447T2 (de) 2005-08-04

Family

ID=10839133

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69918447T Expired - Lifetime DE69918447T2 (de) 1998-09-18 1999-09-17 Antivirale kombinationen von lamivudin und adefovir

Country Status (22)

Country Link
EP (1) EP1113802B1 (de)
JP (1) JP2002526441A (de)
KR (1) KR100413312B1 (de)
CN (1) CN1178660C (de)
AR (1) AR023661A1 (de)
AT (1) ATE270106T1 (de)
AU (1) AU755633B2 (de)
BR (1) BR9913791A (de)
CA (1) CA2344172A1 (de)
CZ (1) CZ2001977A3 (de)
DE (1) DE69918447T2 (de)
ES (1) ES2223183T3 (de)
GB (1) GB9820420D0 (de)
HU (1) HU227677B1 (de)
IL (1) IL141844A0 (de)
NO (1) NO20011358L (de)
NZ (1) NZ510380A (de)
PL (1) PL358988A1 (de)
TR (1) TR200101486T2 (de)
TW (1) TW555559B (de)
WO (1) WO2000016755A2 (de)
ZA (1) ZA200101920B (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA986614B (en) 1997-07-25 1999-01-27 Gilead Sciences Nucleotide analog composition
CA2401569C (en) 2000-02-29 2009-08-18 Bristol-Myers Squibb Company Low dose entecavir formulation and use
CN1303089C (zh) * 2002-11-19 2007-03-07 天津药物研究院 阿德福韦酯结晶形态及其制备方法
US20040224917A1 (en) 2003-01-14 2004-11-11 Gilead Sciences, Inc. Compositions and methods for combination antiviral therapy
UA93354C2 (ru) 2004-07-09 2011-02-10 Гилиад Сайенсиз, Инк. Местный противовирусный препарат
TWI471145B (zh) 2005-06-13 2015-02-01 Bristol Myers Squibb & Gilead Sciences Llc 單一式藥學劑量型
RU2008128424A (ru) * 2005-12-14 2010-01-20 Сипла Лимитед (In) Фармацевтическая комбинация, включающая нуклеотидный и нуклеозидный ингибиторы обратной транскриптазы (такие как тенофовир и ламивудин) в различных частях дозы
AU2010339417A1 (en) * 2009-12-31 2012-08-16 Xiao-jian ZHOU Compositions and methods for treating hepatitis B virus infection
WO2012062835A1 (en) * 2010-11-12 2012-05-18 Glaxo Wellcome Manufacturing Pte Ltd Novel pharmaceutical compositions
WO2022089600A1 (zh) * 2020-10-30 2022-05-05 杭州拉林智能科技有限公司 黄酮苷-有机胺类抗微生物剂复盐化合物及其制备方法和应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4716299A (en) * 1998-06-24 2000-01-10 Emory University Use of 3'-azido-2',3'-dideoxyuridine in combination with further anti-hiv drugs for the manufacture of a medicament for the treatment of hiv

Also Published As

Publication number Publication date
IL141844A0 (en) 2002-03-10
AR023661A1 (es) 2002-09-04
CZ2001977A3 (cs) 2001-08-15
EP1113802A2 (de) 2001-07-11
HUP0103858A3 (en) 2004-03-01
HK1035670A1 (en) 2001-12-07
HUP0103858A2 (hu) 2002-05-29
NZ510380A (en) 2003-07-25
CA2344172A1 (en) 2000-03-30
ATE270106T1 (de) 2004-07-15
KR20010075192A (ko) 2001-08-09
AU6085199A (en) 2000-04-10
GB9820420D0 (en) 1998-11-11
KR100413312B1 (ko) 2004-01-03
CN1178660C (zh) 2004-12-08
BR9913791A (pt) 2001-05-29
DE69918447T2 (de) 2005-08-04
HU227677B1 (en) 2011-11-28
WO2000016755A3 (en) 2000-05-25
TW555559B (en) 2003-10-01
EP1113802B1 (de) 2004-06-30
WO2000016755A2 (en) 2000-03-30
CN1326349A (zh) 2001-12-12
AU755633B2 (en) 2002-12-19
TR200101486T2 (tr) 2001-12-21
ES2223183T3 (es) 2005-02-16
NO20011358L (no) 2001-04-17
PL358988A1 (en) 2004-08-23
JP2002526441A (ja) 2002-08-20
ZA200101920B (en) 2002-03-07
NO20011358D0 (no) 2001-03-16

Similar Documents

Publication Publication Date Title
DE69814069D1 (de) Neuartige form von s-omeprazol
DE69738197D1 (de) Azolotriazine und pyrimidine
DE69930647D1 (de) Struktur-analoga von amin-basen und nucleosiden
MA26668A1 (fr) ACTIVATEURS DE hPPARy ET hPPARa
ATA106797A (de) Anordnung mit bauteilen und bauteile
DE69831755D1 (de) Optoakustische kontrastmittel und anwendungsverfahren
EP0968223A4 (de) Biokonjugation von makromolekülen
PT1032396E (pt) Esterilizacao de glucocorticoesteroides
DE69928195D1 (de) Komplettierung von Untrerdruck-Bohrlöchern
DE69828963D1 (de) Wirstoffabgabe und gentherapiesystem
FI970468A0 (fi) Anvaendningspraoksberoende bokstavsmatning med nummertangenter
DE69820397D1 (de) Ätzmittel und ihre Verwendung
DE69302234D1 (de) Menschliches Prohibitin und Prohibitin kodierende DNS
FI974269A0 (fi) Radiosaendare-mottagarestruktur med tvao frekvensomraoden
DE69916694D1 (de) 2-Hydroxy-5-methyl-hexan-3-on und 3-hydroxy-5-methyl-hexan-2-on
DE69918447D1 (de) Antivirale kombinationen von lamivudin und adefovir
DE69842206D1 (de) Echounterdrücker und echounterdrückungsverfahren
ATE232199T1 (de) Polymorphe modifikationen von dofetilid
ATE231489T1 (de) N-sulphonyl und n-sulphinyl phenylglycinamide
FI974544A0 (fi) Anordning i en med manoeverplats foersedd lastkran
EP1005474A4 (de) Herstellung von polyorganophosphazenen
FI972010A0 (fi) Arrangemang i en borrningsanordning
FI970405A0 (fi) Plattformad traeprodukt med skiktstruktur
FR2763940B1 (fr) Preparation de trifluoromethoxy-2-aniline
ID29414A (id) Pengobatan depresi

Legal Events

Date Code Title Description
8364 No opposition during term of opposition